1. Home
  2. DIT vs PRLD Comparison

DIT vs PRLD Comparison

Compare DIT & PRLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AMCON Distributing Company

DIT

AMCON Distributing Company

HOLD

Current Price

$111.86

Market Cap

70.9M

ML Signal

HOLD

Logo Prelude Therapeutics Incorporated

PRLD

Prelude Therapeutics Incorporated

HOLD

Current Price

$3.23

Market Cap

69.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DIT
PRLD
Founded
1981
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Food Distributors
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
70.9M
69.1M
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
DIT
PRLD
Price
$111.86
$3.23
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$4.00
AVG Volume (30 Days)
654.0
305.5K
Earning Date
04-23-2026
01-01-0001
Dividend Yield
0.89%
N/A
EPS Growth
N/A
16.83
EPS
1.28
N/A
Revenue
$1,392,388,157.00
$7,000,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$87.39
N/A
Revenue Growth
5.30
N/A
52 Week Low
$94.92
$0.61
52 Week High
$129.30
$4.19

Technical Indicators

Market Signals
Indicator
DIT
PRLD
Relative Strength Index (RSI) 51.94 65.64
Support Level $111.63 $0.99
Resistance Level $120.48 $4.19
Average True Range (ATR) 1.35 0.33
MACD 0.03 0.05
Stochastic Oscillator 58.45 87.50

Price Performance

Historical Comparison
DIT
PRLD

About DIT AMCON Distributing Company

Amcon Distributing Co is engaged in the wholesale and retail distribution of consumer products such as cigarettes, tobacco, confectionery, health food, and others. It operates in two segments: Wholesale distribution segment distributing consumer products to the retail outlets including convenience stores, grocery stores, liquor stores, drug stores and tobacco shops in the Central, Rocky Mountain, and Southern regions of the United States; and the Retail health food segment is a specialty retailer of natural/organic groceries and dietary supplements throughout the Midwest and Florida. The company earns a majority of the revenue from the Wholesale distribution segment.

About PRLD Prelude Therapeutics Incorporated

Prelude Therapeutics Incorp is a clinical stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet needs. The company's pipeline includes four candidates currently in clinical development: PRT1419, a potent, selective inhibitor of MCL1; PRT2527, a potent and selective CDK9 inhibitor, PRT3645, a next-generation CDK4/6 inhibitor, and PRT3789 a first-in-class SMARCA2/BRM protein degrader.

Share on Social Networks: